We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > precision

News List

New Late-Breaking Data at The American Diabetes Association Show GlycoMark® May Be an Effective Test for COVID-19 Severity prnasia
June 29, 2021
Precision Diabetes, Inc. and Patia announced results from a study showing that the GlycoMark blood test may be an effective marker of stress hyperglycemia and severity in COVID-19 patients, particularly in patients without diabetes.
Amgen, Syapse Enter Precision Medicine Pact contractpharma
May 16, 2019
To develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.
Precision, MaxCyte Enter Clinical Agreement contractpharma
November 19, 2018
Precision BioSciences (Precision) and MaxCyte have entered into a non-exclusive, clinical and commercial license agreeme
Precision, MaxCyte Enter Clinical Agreement contractpharma
November 18, 2018
Allows Precision to use MaxCyte's Flow Electroporation® technologies to robustly deliver ARCUS genome-editing technology
Gilead, Precision to co-develop hepatitis B therapies pharmatimes
September 18, 2018
Gilead and Precision BioSciences are to work together on developing gene-editing treatments against hepatitis B.